Trellis Bioscience is Biotechnology in United States that focus on immune system business. Founded in 1998. They cover business area such as operator, proprietary CellSpot technology, rare, naturally optimize antibody, healthy donor blood, infectious disease, cancer, therapeutic antibody, Optimize human-derive antibody, client, access, alternative, protein therapeutic, patient, safe and effective medical care.
1998
( 26 years old in 2024 )
Immune System
-
702 Marshall Street
Suite 614
Redwood City, CA 94063
United States
Private
operatorproprietary CellSpot technologyrare, naturally optimize antibodyhealthy donor bloodinfectious diseasecancertherapeutic antibodyOptimize human-derive antibodyclientaccessalternativeprotein therapeuticpatientsafe and effective medical care
* We use standard office opening hours in near Trellis Bioscience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Trellis Bioscience is Biotechnology business from United States that founded in 1998 (26 years old in 2024), Trellis Bioscience business is focusing on Immune System.
Trellis Bioscience headquarter office and corporate office address is located in 702 Marshall Street Suite 614 Redwood City, CA 94063 United States.
Trellis Bioscience was founded in United States.
In 2024, Trellis Bioscience is currently focus on immune system sector.
Above is snippet of Google Trends for "immune system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Trellis Bioscience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.